Journey Strategic Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.86M Buy
32,079
+1,321
+4% +$153K 0.1% 63
2025
Q4
$3.24M Buy
30,758
+2,640
+9% +$248K 0.09% 65
2025
Q3
$2.36M Buy
28,118
+5,972
+27% +$492K 0.07% 83
2025
Q2
$1.75M Buy
22,146
+6,930
+46% +$551K 0.06% 103
2025
Q1
$1.37M Sell
15,216
-235
-2% -$21.9K 0.05% 101
2024
Q4
$1.54M Sell
15,451
-1,373
-8% -$142K 0.06% 87
2024
Q3
$1.91M Buy
16,824
+3,343
+25% +$397K 0.07% 76
2024
Q2
$1.67M Buy
13,481
+3,012
+29% +$388K 0.07% 58
2024
Q1
$1.38M Buy
10,469
+1,104
+12% +$136K 0.06% 57
2023
Q4
$1.02M Buy
9,365
+630
+7% +$65.4K 0.05% 63
2023
Q3
$899K Buy
8,735
+224
+3% +$24.1K 0.04% 63
2023
Q2
$982K Sell
8,511
-2,419
-22% -$275K 0.04% 57
2023
Q1
$1.16M Sell
10,930
-366
-3% -$39.5K 0.12% 52
2022
Q4
$1.25M Buy
11,296
+2,514
+29% +$257K 0.15% 50
2022
Q3
$757K Buy
8,782
+3,379
+63% +$302K 0.1% 50
2022
Q2
$493K Sell
5,403
-2,451
-31% -$217K 0.07% 58
2022
Q1
$645K Buy
7,854
+1,850
+31% +$146K 0.07% 40
2021
Q4
$460K Buy
+6,004
New +$478K 0.05% 77

Other funds holding MRK

Journey Strategic Wealth's MRK Position: Q1 2026 in Review

Journey Strategic Wealth increased its Merck (MRK) stake by 4.3% in Q1 2026, buying an estimated $153K and bringing the position to 32,079 shares worth $3.86M. The position accounts for 0.1% of the portfolio, ranked #63.

Journey Strategic Wealth first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Journey Strategic Wealth held 32,079 shares of Merck worth $3.86M as of Q1 2026.
  • Journey Strategic Wealth bought 1,321 Merck shares in Q1 2026, an estimated $153K.
  • Merck made up 0.1% of Journey Strategic Wealth's portfolio in Q1 2026, its #63 holding.
  • Journey Strategic Wealth first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.